Ghent University Academic Bibliography

Advanced

Time-saving screening for diabetes in patients with coronary artery disease : a report from EUROASPIRE IV

Viveca Gyberg, Dirk De Bacquer UGent, Kornelia Kotseva, Gui De Backer UGent, Oliver Schnell, Jaakko Tuomilehto, David Wood and Lars Ryden (2016) BMJ OPEN. 6(12).
abstract
Background: WHO advocates 2-hour oral glucose tolerance test (OGTT) for detecting diabetes mellitus (DM). OGTT is the most sensitive method to detect DM in patients with coronary artery disease (CAD). Considered time consuming, the use of OGTT is unsatisfactory. A 1-hour plasma glucose (1hPG) test has not been evaluated as an alternative in patients with CAD. Objectives: To create an algorithm based on glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and 1hPG limiting the need of a 2-hour plasma glucose (2hPG) in patients with CAD. Methods: 951 patients with CAD without DM underwent OGTT. A 2hPG >= 11.1 mmol/L was the reference for undiagnosed DM. The yield of HbA1c, FPG and 1hPG was compared with that of 2hPG. Results: Mean FPG was 6.2 +/- 0.9 mmol/L, and mean HbA1c 5.8 +/- 0.4%. Based on 2hPG >= 11.1 mmol/L 122 patients (13%) had DM. There was no value for the combination of HbA1c and FPG to rule out or in DM (HbA1c >= 6.5%; FPG >= 7.0 mmol/L). In receiver operating characteristic analysis a 1hPG >= 12 mmol/L balanced sensitivity and specificity for detecting DM (both=82%; positive and negative predictive values 40% and 97%). A combination of FPG<6.5 mmol/L and 1hPG<11 mmol/L excluded 99% of DM. A combination of FPG>8.0 mmol/L and 1hPG>15 mmol/L identified 100% of patients with DM. Conclusions: Based on its satisfactory accuracy to detect DM an algorithm is proposed for screening for DM in patients with CAD decreasing the need for a 2-hour OGTT by 71%.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
ACUTE MYOCARDIAL-INFARCTION, GLUCOSE-TOLERANCE TEST, HOUR POSTLOAD, HYPERGLYCEMIA, FASTING PLASMA-GLUCOSE, CARDIOVASCULAR-DISEASE, EURO, HEART, RISK, MELLITUS, BLOOD, ATHEROSCLEROSIS
journal title
BMJ OPEN
BMJ Open
volume
6
issue
12
article number
e013835
pages
7 pages
Web of Science type
Article
Web of Science id
000391303600055
JCR category
MEDICINE, GENERAL & INTERNAL
JCR impact factor
2.369 (2016)
JCR rank
38/154 (2016)
JCR quartile
1 (2016)
ISSN
2044-6055
DOI
10.1136/bmjopen-2016-013835
language
English
UGent publication?
yes
classification
A1
copyright statement
Creative Commons Attribution 4.0 International Public License (CC-BY 4.0)
id
8510571
handle
http://hdl.handle.net/1854/LU-8510571
date created
2017-02-21 10:53:28
date last changed
2017-05-24 13:47:31
@article{8510571,
  abstract     = {Background: WHO advocates 2-hour oral glucose tolerance test (OGTT) for detecting diabetes mellitus (DM). OGTT is the most sensitive method to detect DM in patients with coronary artery disease (CAD). Considered time consuming, the use of OGTT is unsatisfactory. A 1-hour plasma glucose (1hPG) test has not been evaluated as an alternative in patients with CAD. 
Objectives: To create an algorithm based on glycated haemoglobin (HbA1c), fasting plasma glucose (FPG) and 1hPG limiting the need of a 2-hour plasma glucose (2hPG) in patients with CAD. 
Methods: 951 patients with CAD without DM underwent OGTT. A 2hPG {\textrangle}= 11.1 mmol/L was the reference for undiagnosed DM. The yield of HbA1c, FPG and 1hPG was compared with that of 2hPG. 
Results: Mean FPG was 6.2 +/- 0.9 mmol/L, and mean HbA1c 5.8 +/- 0.4\%. Based on 2hPG {\textrangle}= 11.1 mmol/L 122 patients (13\%) had DM. There was no value for the combination of HbA1c and FPG to rule out or in DM (HbA1c {\textrangle}= 6.5\%; FPG {\textrangle}= 7.0 mmol/L). In receiver operating characteristic analysis a 1hPG {\textrangle}= 12 mmol/L balanced sensitivity and specificity for detecting DM (both=82\%; positive and negative predictive values 40\% and 97\%). A combination of FPG{\textlangle}6.5 mmol/L and 1hPG{\textlangle}11 mmol/L excluded 99\% of DM. A combination of FPG{\textrangle}8.0 mmol/L and 1hPG{\textrangle}15 mmol/L identified 100\% of patients with DM. 
Conclusions: Based on its satisfactory accuracy to detect DM an algorithm is proposed for screening for DM in patients with CAD decreasing the need for a 2-hour OGTT by 71\%.},
  articleno    = {e013835},
  author       = {Gyberg, Viveca and De Bacquer, Dirk and Kotseva, Kornelia and De Backer, Gui and Schnell, Oliver and Tuomilehto, Jaakko and Wood, David and Ryden, Lars},
  issn         = {2044-6055},
  journal      = {BMJ OPEN},
  keyword      = {ACUTE MYOCARDIAL-INFARCTION,GLUCOSE-TOLERANCE TEST,HOUR POSTLOAD,HYPERGLYCEMIA,FASTING PLASMA-GLUCOSE,CARDIOVASCULAR-DISEASE,EURO,HEART,RISK,MELLITUS,BLOOD,ATHEROSCLEROSIS},
  language     = {eng},
  number       = {12},
  pages        = {7},
  title        = {Time-saving screening for diabetes in patients with coronary artery disease : a report from EUROASPIRE IV},
  url          = {http://dx.doi.org/10.1136/bmjopen-2016-013835},
  volume       = {6},
  year         = {2016},
}

Chicago
Gyberg, Viveca, Dirk De Bacquer, Kornelia Kotseva, Gui De Backer, Oliver Schnell, Jaakko Tuomilehto, David Wood, and Lars Ryden. 2016. “Time-saving Screening for Diabetes in Patients with Coronary Artery Disease : a Report from EUROASPIRE IV.” Bmj Open 6 (12).
APA
Gyberg, V., De Bacquer, D., Kotseva, K., De Backer, G., Schnell, O., Tuomilehto, J., Wood, D., et al. (2016). Time-saving screening for diabetes in patients with coronary artery disease : a report from EUROASPIRE IV. BMJ OPEN, 6(12).
Vancouver
1.
Gyberg V, De Bacquer D, Kotseva K, De Backer G, Schnell O, Tuomilehto J, et al. Time-saving screening for diabetes in patients with coronary artery disease : a report from EUROASPIRE IV. BMJ OPEN. 2016;6(12).
MLA
Gyberg, Viveca, Dirk De Bacquer, Kornelia Kotseva, et al. “Time-saving Screening for Diabetes in Patients with Coronary Artery Disease : a Report from EUROASPIRE IV.” BMJ OPEN 6.12 (2016): n. pag. Print.